Legislative Assembly for the ACT: 1999 Week 4 Hansard (22 April) . . Page.. 1259 ..
Mr Stanhope asked the Minister for Health and Community Care, upon notice, on 24 March 1999:
In relation to the report ' Survival' commissioned by Assisting Drug Dependents Incorporated (ADDInc), which examines the administration and activities of the ACT Intravenous League (ACTIV) which was at the time in receipt of ACT Government funding,
(1) Why did the Department fail to respond to the problem of duplication of data
found in ACTIV's Output Reports (pages 8-9 of the report).
(2) Will the contract, now entered into, with Canberra Injector Network (CIN)
address the following problems identified in the report
(a) the keeping of attendance records and leave arrangements (page 11);
(b) the inability to confirm the validity of client contact data (page 2);
(c) a number of issues identified by staff during consultations about irregularities with ACTIV's organisational management, including;
intimidation of staff;
inadequate attendance accountability;
approval of undocumented leave;
lack of processes for backfilling vacant positions;
lack of processes for appointing casual staff;
lack of processes for assessing and addressing the fitness of staff to attend work;
lack of staff supervision;
inappropriate workplace behaviour;
preferential service provision; and
lack of service provision.
(3) What was done to address the alleged behaviour identified in the report that
there was evidence that some staff were driving motor vehicles while
unlicensed, or driving unregistered vehicles or that unlicensed drivers were
driving "organisational motor vehicles during work hours".
(4) Has there been a review of the location and viability of the drop-in facility as
suggested in the report (see page 12), if so, can you table a copy of the review.
(5) The report identified two projects which were not completed by ACTIV, the
monetary value of which was approximately one third of the total value
($74,197) of the seven projects, between 1994/95 and 1996/97 (see page 14)